4/19
05:19 pm
nlsp
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing [Yahoo! Finance]
Medium
Report
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing [Yahoo! Finance]
4/19
05:00 pm
nlsp
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
Medium
Report
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
3/22
04:52 pm
nlsp
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering [Yahoo! Finance]
Medium
Report
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering [Yahoo! Finance]
3/22
04:30 pm
nlsp
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
Medium
Report
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
3/20
01:56 pm
nlsp
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering [Yahoo! Finance]
High
Report
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering [Yahoo! Finance]
3/20
01:40 pm
nlsp
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
High
Report
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
3/20
07:34 am
nlsp
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform [Yahoo! Finance]
High
Report
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform [Yahoo! Finance]
3/20
07:30 am
nlsp
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
High
Report
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
3/14
08:12 am
nlsp
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event [Yahoo! Finance]
Medium
Report
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event [Yahoo! Finance]
3/14
08:00 am
nlsp
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
Medium
Report
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
3/11
07:00 am
nlsp
Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
High
Report
Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
2/23
07:49 am
nlsp
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq [Yahoo! Finance]
Low
Report
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq [Yahoo! Finance]
2/23
07:30 am
nlsp
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
Low
Report
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq